MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$22,170,414
Accounts receivable,
non-trade
$1,109,908
Restricted cash
$79,647
Prepaid insurance
expense
$26,954
Total current assets
$23,386,923
Goodwill
$8,737,953
Intangible assets, net
$4,473,426
Total assets
$36,598,302
Total liabilities and
shareholders equity
$36,598,302
Total shareholders
equity
$29,700,824
Total liabilities
$6,897,478
Accumulated deficit
-$186,389,115
Accumulated other
comprehensive loss, net of tax
-$2,225,265
Additional paid-in
capital, net of...
$218,315,150
Accompanying warrants
liability
$2,712,784
Total current
liabilities
$2,586,308
Contingent consideration
$1,172,859
Deferred tax liability
$425,527
Common stock, 0.00001
par value,...
$54
Accrued expenses and
other current...
$2,065,599
Accounts payable
$520,709
Back
Back
Balance Sheet
source: myfinsight.com
Neuphoria Therapeutics Inc. (NEUP)
Neuphoria Therapeutics Inc. (NEUP)